End-of-day quote
Saudi Arabian S.E.
06:00:00 2024-05-01 pm EDT
|
5-day change
|
1st Jan Change
|
37.35
SAR
|
-0.53%
|
|
-1.06%
|
-1.19%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,270
|
4,704
|
4,722
|
2,614
|
4,536
|
4,482
|
-
|
-
|
Enterprise Value (EV)
1 |
4,101
|
5,596
|
5,688
|
3,340
|
5,380
|
5,438
|
5,332
|
5,428
|
P/E ratio
|
-7.55
x
|
37.7
x
|
179
x
|
-15.8
x
|
-344
x
|
50.5
x
|
28.9
x
|
22.3
x
|
Yield
|
-
|
2.55%
|
1.52%
|
2.75%
|
-
|
0.97%
|
2.17%
|
2.35%
|
Capitalization / Revenue
|
2.11
x
|
3.02
x
|
3.23
x
|
1.83
x
|
2.74
x
|
2.38
x
|
2.11
x
|
1.9
x
|
EV / Revenue
|
2.64
x
|
3.59
x
|
3.9
x
|
2.34
x
|
3.25
x
|
2.89
x
|
2.51
x
|
2.3
x
|
EV / EBITDA
|
175
x
|
23.3
x
|
39.6
x
|
-93.3
x
|
29.6
x
|
21.6
x
|
17.6
x
|
14.6
x
|
EV / FCF
|
255
x
|
-36.1
x
|
-
|
-
|
-84.5
x
|
62.5
x
|
45.8
x
|
-
|
FCF Yield
|
0.39%
|
-2.77%
|
-
|
-
|
-1.18%
|
1.6%
|
2.18%
|
-
|
Price to Book
|
1.69
x
|
2.46
x
|
2.57
x
|
1.7
x
|
3.01
x
|
2.77
x
|
2.6
x
|
2.39
x
|
Nbr of stocks (in thousands)
|
120,000
|
120,000
|
120,000
|
120,000
|
120,000
|
120,000
|
-
|
-
|
Reference price
2 |
27.25
|
39.20
|
39.35
|
21.78
|
37.80
|
37.35
|
37.35
|
37.35
|
Announcement Date
|
3/31/20
|
3/30/21
|
3/31/22
|
3/23/23
|
3/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,553
|
1,559
|
1,460
|
1,426
|
1,653
|
1,882
|
2,123
|
2,357
|
EBITDA
1 |
23.42
|
240.6
|
143.6
|
-35.8
|
181.6
|
251.7
|
302.7
|
372.4
|
EBIT
1 |
-313.9
|
153.2
|
55.5
|
-126.1
|
89.4
|
159.3
|
224
|
259.4
|
Operating Margin
|
-20.22%
|
9.82%
|
3.8%
|
-8.84%
|
5.41%
|
8.47%
|
10.55%
|
11%
|
Earnings before Tax (EBT)
1 |
-446.9
|
158
|
-
|
-
|
36.2
|
156
|
226
|
-
|
Net income
1 |
-478.6
|
124.8
|
-
|
-
|
-13.7
|
77.74
|
152.2
|
229.4
|
Net margin
|
-30.83%
|
8%
|
-
|
-
|
-0.83%
|
4.13%
|
7.17%
|
9.73%
|
EPS
2 |
-3.610
|
1.040
|
0.2200
|
-1.380
|
-0.1100
|
0.7393
|
1.293
|
1.674
|
Free Cash Flow
1 |
16.06
|
-155
|
-
|
-
|
-63.68
|
159
|
209
|
119
|
FCF margin
|
1.03%
|
-9.94%
|
-
|
-
|
-3.85%
|
8.45%
|
9.84%
|
5.05%
|
FCF Conversion (EBITDA)
|
68.6%
|
-
|
-
|
-
|
-
|
63.16%
|
69.05%
|
31.95%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
204.52%
|
137.35%
|
51.86%
|
Dividend per Share
2 |
-
|
1.000
|
0.6000
|
0.6000
|
-
|
0.3622
|
0.8097
|
0.8789
|
Announcement Date
|
3/31/20
|
3/30/21
|
3/31/22
|
3/23/23
|
3/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
532
|
409
|
382
|
330.7
|
632
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
57
|
22
|
-38
|
-
|
73
|
Net margin
|
10.71%
|
5.38%
|
-9.95%
|
-
|
11.55%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/16/23
|
8/8/23
|
11/6/23
|
3/31/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
831
|
892
|
966
|
726
|
844
|
956
|
850
|
946
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
35.48
x
|
3.706
x
|
6.73
x
|
-20.29
x
|
4.646
x
|
3.798
x
|
2.808
x
|
2.539
x
|
Free Cash Flow
1 |
16.1
|
-155
|
-
|
-
|
-63.7
|
159
|
209
|
119
|
ROE (net income / shareholders' equity)
|
-19.5%
|
6.47%
|
1.41%
|
-9.78%
|
-0.9%
|
5.76%
|
9.35%
|
12.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-0.35%
|
1.8%
|
3.22%
|
4.34%
|
Assets
1 |
-
|
-
|
-
|
-
|
3,924
|
4,324
|
4,723
|
5,287
|
Book Value Per Share
2 |
16.10
|
16.00
|
15.30
|
12.80
|
12.60
|
13.50
|
14.40
|
15.60
|
Cash Flow per Share
2 |
2.910
|
0.0800
|
0.7200
|
-1.040
|
0.4000
|
0.3800
|
0.8500
|
1.520
|
Capex
1 |
319
|
165
|
76.2
|
84.6
|
111
|
134
|
118
|
174
|
Capex / Sales
|
20.56%
|
10.56%
|
5.22%
|
5.93%
|
6.74%
|
7.12%
|
5.55%
|
7.38%
|
Announcement Date
|
3/31/20
|
3/30/21
|
3/31/22
|
3/23/23
|
3/31/24
|
-
|
-
|
-
|
Last Close Price
37.35
SAR Average target price
36.64
SAR Spread / Average Target -1.90% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.19% | 1.19B | | +26.73% | 681B | | +21.85% | 556B | | -4.84% | 361B | | +16.98% | 325B | | +5.70% | 285B | | +13.68% | 235B | | +3.65% | 199B | | -11.12% | 189B | | -3.80% | 157B |
Other Pharmaceuticals
|